Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 15 Biotechnology Angel Investors in Singapore in February 2025

Last updated: Feb 2025 A list of 15 angel investors that invest in Biotechnology startups based in Singapore. We rank investors based on the number of investments they made in Biotechnology companies from Singapore. We update this investor list every month.

Top 15 Biotechnology Angel Investors in Singapore in February 2025

Investor	Biotechnology Singapore investments
Johannes Hille	1
Ron Sim	1
Alice Foo	1
Eric Urhane	1
Benjamin Boyer	1
Roy Oron	1
Quek Siu Rui	1
Jeffrey Tiong	1
Feng Hu	1
Nadav Rosenberg	1
Bud Biswas	1
Paul Buchheit	1
Jack Wang	1
Frederik Vandermarlie	1
Matt Cutts	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Johannes Hille

Investment focus

Medical, Health Care, Biotechnology
Seed
Singapore

Portfolio highlights

X-ZELL — Early, pain-free cancer cell detection

Ron Sim

Investment focus

Beauty, Fitness, Genetics
Series A
Singapore

Portfolio highlights

Imagene Labs — Imagene Labs Pte Ltd empowers consumers to optimise their health by providing customised wellness and lifestyle solutions tailored to their unique DNA profiles. Led by medical doctors and scientists, the company provides an entire ecosystem of genomics-based solutions ranging from wellness DNA tests, personalised lifestyle recommendations, bespokeskin serums and nutritional supplements, and mobile health apps that help people live, look and feel their best.

Alice Foo is an angel investor for Alterpacks.

Investment focus

Recycling, Biotechnology, Waste Management
Pre-Seed
Singapore

Portfolio highlights

AlterPacks — Alterpacks - Food Waste Solutions. A Singapore Management University, Institute of Innovation & Entrepreneurship, Business Innovation Generator (BIG) Incubatee.

Eric Urhane

Investment focus

Software, Health Care, Biotechnology
Seed, Angel
United States, Mexico, Singapore

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
X-ZELL — Early, pain-free cancer cell detection
Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.

Ben Boyer is a Managing Director of Tenaya Capital, and he has been a member of the Tenaya investment team since 2000.Previously, Ben was a member of Lehman Brothers' Technology Investment Banking group, where he was responsible for corporate finance and strategic advisory assignments.Ben holds an M.B.A. from Stanford Graduate Schoolof Business and a B.S. in human and organizational development from Vanderbilt University.

Investment focus

Software, E-Commerce, Internet
Series C, Seed, Series B
United States, China, Singapore

Portfolio highlights

Kangaroo — No hidden upfront costs or astronomical monthly monitoring fees. Our plans are contract-free, flexible and affordable. We even help you earn cash back on your insurance policy! Our sensors are batteries-included, peel-and-stick, app-controlled easy. Choose a free plan or professionally monitored plan for only $99/yr.
People.ai — Uncover the Fastest Path to Revenue
Triparound — Get access to the ultimate travel planning platform for maximized ancillary revenue and operational efficiency!

Roy Oron is the founder and general partner at ITI Venture Capital Partners.

Investment focus

Software, Mobile, Biotechnology
Seed, Series B, Series A
United States, Israel, Singapore

Portfolio highlights

Vayyar — Vayyar is the global leader in 4D imaging radar technology, providing affordable, highly advanced sensors to a wide variety of industries.
Enzootic — Enzootic is a vertically integrated genetic freshwater shrimp company
proteanTecs — proteanTecs' platform applies machine learning & analytics to data from chip-embedded Agents providing insights & predictions on performance and reliability.

Siu Rui is a co-founder of Carousell and oversees Product and Marketing. Since the launch of Carousell in May 2012 together with co-founders Marcus Tan and Lucas Ngoo, Siu Rui has been deeply involved in product strategy, international expansion and capital strategy. He is passionate about technology and has been buying and selling online since hewas 13. This has been a driving force behind Siu Rui’s commitment to building a product-focused company, focused on solving meaningful problems for people globally.Prior to Carousell, Siu Rui spent some time in marketing and product management at VSee, Ogilvy & Mather and DBS Vickers. Siu Rui read Business Administration and Entrepreneurship at National University of Singapore and Stanford University (Under the NUS Overseas College Program in Silicon Valley, California), and dropped out of his Honours year to start Carousell.

Investment focus

Health Care, Education, Information Technology
Seed, Pre-Seed, Series A
Singapore, Indonesia

Portfolio highlights

NodeFlair — NodeFlair aims to help tech talents make better career decisions through jobs, salaries, reviews, company insights, and more
Mito Health — An AI-Powered medical team dedicated to optimising your health. Focusing on in-depth diagnostics and evidence-based strategies across 5 key pillars of nutrition, sleep, exercise, supplements and mental well-being.
Circular — We are making subscriptions the best way to experience tech. Circular aims to accelerate the circular economy and maximise the useful lives of each tech device to its fullest potential.

Jeffrey is passionate about leveraging technology to help companies innovate more successfully. Since founding PatSnap fresh out of college, Jeffrey’s unique ability to merge technology, product design, strategy and marketing has helped it become the fastest-growing company in the industry, with operations across Singapore, China and London.Jeffrey sets the vision for the company and its products, and drives relentless execution across all fronts. Jeffrey earned a Bachelor’s degree in Biomedical Engineering from the National University of Singapore.

Investment focus

Health Care, Apps, Medical
Pre-Seed, Seed
Singapore

Portfolio highlights

MindFi — MindFi is an employee mental health and well-being app delivering personalized self-care recommendations, support, and behavioral coaches. MindFi enables people to achieve peak mental performance.
Mito Health — An AI-Powered medical team dedicated to optimising your health. Focusing on in-depth diagnostics and evidence-based strategies across 5 key pillars of nutrition, sleep, exercise, supplements and mental well-being.
StratifiCare — At StratifiCare, we focus on the development and manufacturing of IVD (In-Vitro Diagnostics) assay solutions for personalized medicine. With more than 50 years of cumulative in-depth experience in Biomedical R&D and technology commercialization, StratifiCare strives to empower personalised medicine.

Feng Hu

Investment focus

Communities, Mobile Apps, Health Care
Seed, Pre-Seed, Convertible Note
United States, India, Singapore

Portfolio highlights

Credy — Credy provides instant online loan at low interest rate. Apply now for personal loan, education loan, medical loan, credit refinancing or other loans.
DIVE - Dating With Games — DIVE-Dating With Gaming is a trendy dating and gaming app. It offers super interesting roleplay games that break the ice and that lead to deeper and more fun experiences between matches.
Audetemi Inc. — Audetemi makes it easy for enterprises to enable their business on mobile, and create a superior, and engaging customer experience. Audetemi One platform allows businesses to effectively engage their customers by seamlessly integrating traditional customer engagement platforms onto their smartphones.

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Investment focus

Biotechnology, Artificial Intelligence, Pharmaceutical
Seed, Pre-Seed, Series A
United Kingdom, Israel, Singapore

Portfolio highlights

thymia — Making mental health as objectively measurable as physical health.
Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Loops — With Loops causal insights you can identify your biggest opportunities to maximize your KPIs... try the Loops way

Bud has an impressive track record of starting networking companies and turning them into profitable businesses, and has over twenty years of industry experience in the field of high speed networking, in both technical and managerial positions. He founded Digital Technology, which was acquired by Agilent Technologies in the year 2000. He was alsoone of the founding partners of Network Software, a networking consulting company, and CCS, one of the first portable PC companies of the early 80's. Bud has an MS in Electrical Engineering and an MS in Computer Science from Ann Arbor, Michigan.

Investment focus

Health Care, Biotechnology, Health Diagnostics
Seed
Singapore

Portfolio highlights

Cardiotrack — uber Diagnostics is engaged in mHealth space to deliver diagnostics solutions that significantly improve patient care in developing nations. Key challenges faced by healthcare providers include very high cost of diagnostics equipment and lack of trained professionals in semi-urban and rural areas. uber Diagnostics is addressing both of theseissues through innovation in medical electronics and research in cloud based IT infrastructure.

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

Investment focus

Software, E-Commerce, Health Care
Seed, Series A, Angel
United States, Canada, India

Portfolio highlights

SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
Character.ai — Chat with millions of AI Characters anytime, anywhere. Super-intelligent chat bots that hear you, understand you, and remember you. Free to use with no ads.
Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.

Jack Wang

Investment focus

Fertility, Biotechnology, Medical Device
Seed
Singapore

Portfolio highlights

Hannah Life Technologies — We make Earth's best products and services for couples in their parenthood journey.

Frederik Vandermarlie

Investment focus

Medical, Legal Tech, Health Care
Seed
Belgium, Singapore

Portfolio highlights

X-ZELL — Early, pain-free cancer cell detection
Henchman — Effortlessly find the clauses you’re looking for by applying our AI to your existing contracts.

Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his

Investment focus

SaaS, Health Care, Software
Seed, Angel, Series A
United States, Canada, Mexico

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
X-ZELL — Early, pain-free cancer cell detection
Meter Feeder — Easily pay for parking through MeterFeeder

Investors by industry

Artificial intelligence